EPCAM and neoplasm: The findings of our study indicate that EpCAM-positive EVs levels in ascites of patients with advanced HGSC have potential as prognostic biomarkers for predicting early recurrence and thereby likelihood of more aggressive tumor biology and development of chemoresistance.